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Leishmania LeIF antigen, homologous to eukaryotic
initiation factor eIF4A, was originally described as a
Th1-type natural adjuvant and as an antigen that
induces an IL-12-mediated Th1 response in the periph-
eral blood mononuclear cells (PBMC) of leishmaniasis
patients. We aimed at addressing the role of this protein
and defining the minimum fragment necessary for indu-
cing cytokine secretion. The study necessitated expres-
sion cloning of LeIF and 9 domains. Comparative
biochemical and genetic analyses of LeIF and yeast
eIF4A showed that LieIF is both an RNA-dependent
ATPase and ATP-dependent RNA helicase in vitro and
highlighted differences with yeast protein. In vivo experi-
ments in yeast showed that LeIF cannot complement the
deletion of the essential TIF1 and TIF2 genes in the
yeast Saccharomyces cerevisiae that encode eIF4A. How-
ever, expression of LeIF results in a dominant negative
phenotype, which is abolished by deletion of the most
divergent 25 N-terminal residues. LeIF is able to interact
with yeast eIF4G; this suggested a role in the translation
machinery. The assays measuring production of cyto-
kines IL-12p70, IL-10 and TNF-a by PBMC-derived
monocytes of healthy donors exposed to the different
proteins showed that LieIF was able to induce the secre-
tion of these cytokines. Unlike previous reports on LeIF
from L. braziliensis and L. major, both amino and car-
boxyl parts of the protein were shown to induce the
secretion of cytokines at significant levels. Our results
suggest that this activity could be primarily located in
amino acids 1-129 and 261-403. Furthermore, the
induction of cytokines in monocytes of healthy subjects
is not unique to the Leishmania protein. Indeed, 5
homologous proteins DEAD box in mammals and yeast
were also able to induce the secretion of cytokines. This
study confirms the importance of LeIF protein as a vac-
cine target and underscores its potential as drug target.
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